RDY

Dr Reddys Laboratories Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Momentum↑ 5/10
Dr Reddys Laboratories sales and earnings growth
RDY Growth
Great
  • Revenue Y/Y↑ 71.59%
  • EPS Y/Y↑ 226.53%
  • FCF Y/Y↓ -51.85%
Dr Reddys Laboratories gross and profit margin trends
RDY Profitability
Great
  • Gross margin ↑ 58.50%
  • EPS margin↑ 17.40%
  • ROIC↑ 28.70%
Dr Reddys Laboratories recent dividend growth
RDY Dividends
  • Dividend yield 0.00%
  • Growth 3Y↑ 27.56%
  • Payout ratio↑ 0%
Dr Reddys Laboratories net debt vs free cash flow
RDY Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 2.6
  • Interest coverage↑ 27.9

Dr Reddys Laboratories stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗